News Daily News Hospital Culture, Physician Preference Mostly Drive IVUS/OCT in PCI L.A. McKeown October 24, 2022
News Features From Mountains to Meds: A Grassroots Effort Is Restocking Cath Labs in Ukraine L.A. McKeown October 18, 2022
News Daily News Two RCTs Add Needed Evidence for Thrombectomy in Basilar Occlusion L.A. McKeown October 13, 2022
News Conference News TCT 2022 FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years L.A. McKeown September 20, 2022
News Conference News TCT 2022 SCAAR Registry Delves Into Left Main Revascularization Outcomes Michael O'Riordan September 19, 2022
News Daily News COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK Michael O'Riordan September 15, 2022
News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Daily News IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document L.A. McKeown August 05, 2022
News Conference News TVT 2022 More Support for Single Antiplatelet Therapy After TAVI Michael O'Riordan June 10, 2022
News Daily News Reassuring Data—and Some Lessons—From Pregnancy-Related SCAD Registry Caitlin E. Cox June 08, 2022
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2022 Shelley Wood June 01, 2022
News Daily News Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy L.A. McKeown June 01, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News HRS 2022 EP’s Diversity Problem: Women, Minorities Remain Underrepresented Todd Neale May 06, 2022
News Daily News Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities Michael O'Riordan April 25, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Conference News ACC 2022 FLAVOUR: FFR as Good as IVUS for Intermediate Coronary Stenoses Michael O'Riordan April 06, 2022
News Daily News Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention Michael O'Riordan March 30, 2022